A Levitzki
Hebrew University of Jerusalem(IL)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, PI3K/AKT/mTOR signaling in cancer, Chronic Myeloid Leukemia Treatments, Protein Kinase Regulation and GTPase Signaling, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor(1996)911 cited
- → Crystal Structure of Hck in Complex with a Src Family–Selective Tyrosine Kinase Inhibitor(1999)425 cited
- Flk-1 as a target for tumor growth inhibition.(1996)
- → The effect of tyrosine-specific protein phosphorylation on the assembly of adherens-type junctions.(1992)309 cited
- → Tyrphostins Inhibit Epidermal Growth Factor (EGF)-Receptor Tyrosine Kinase Activity in Living Cells and EGF-Stimulated Cell Proliferation(1989)280 cited
- → Protein Tyrosine Kinase Inhibitors as Novel Therapeutic Agents(1999)214 cited
- → Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiate(1993)129 cited
- → Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells(1991)118 cited
- → Potential 18F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase(2001)89 cited
- Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.(1996)